But the stocks are rising because investors see a path toward federal legalization as more states vote for it. Canadian pot growers need federal legalization to be able to enter the U.S. market, but Aphria and Canopy Growth have been actively preparing for the possibility.
Full Answer
What happened to Aphria stock after the Tilray merger?
Feb 16, 2021 · As of 3 p.m. EST, Aphria's stock price was up more than 25%. So what Cantor Fitzgerald analyst Pablo Zuanic reiterated his overweight rating on Aphria's shares and boosted his one-year price ...
What are the drivers of Aphria stock?
Aphria's stock could deliver handsome returns to shareholders. Image source: Getty Images. Zuanic predicts that Aphria will deliver sequential sales growth of 25% in …
What happened to Aphria’s CEO?
Feb 18, 2021 · Shortly after Aphria’s Q2 results, Stifel analyst Andrew Carter increased the stock’s target price to $15.5, up from $9.8, and maintained a neutral rating on it. Merger with Tilray. Another major...
Why did Aphria’s revenue grow sequentially?
Mar 01, 2021 · But the stocks are rising because investors see a path toward federal legalization as more states vote for it. Canadian pot growers need federal legalization to …
Is Aphria a good stock to buy now?
Currently, Aphria is trading at close to 0.73 times Tilray's share price. The single most compelling reason to buy Aphria stock right now is that this ratio absolutely must increase to the 0.8381 ratio included in the merger agreement.Mar 11, 2021
Is Aphria expected to rise?
Earnings for Aphria are expected to grow in the coming year, from ($0.06) to $0.07 per share.
Is Aphria a good long term investment?
Because Aphria is relatively undervalued, the long-term return of its stock is likely to be higher than its business growth, which averaged 125.7% over the past three years and is estimated to grow 26.56% annually over the next three to five years.Mar 28, 2021
Should I sell Aphria stock?
Stockchase rating for Aphria Inc is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.
What will happen to Aphria stock after merger?
What will happen to Aphria once the arrangement is completed? Once completed, Tilray will acquire all outstanding Aphria Shares and Aphria will become a wholly-owned subsidiary of Tilray. Aphria Shares will be delisted from the TSX and NASDAQ.
Is Aphria stock delisted?
Rivals Canopy Growth Corp and Aphria Inc also moved their U.S. listings to the Nasdaq in 2020, citing lower costs. Aphria delisted this year after its reverse merger with Nasdaq-listed Tilray . Aurora's shares will start trading on the Nasdaq on May 25 under the ticker symbol “ACB.”May 13, 2021
Will Aphria stock become Tilray?
After Tilray's (TLRY) shareholders voted in favor of the proposed merger Aphria (APHA) last Friday, the two cannabis companies announced today the completion of the transaction.May 3, 2021
Did Aphria buy Tilray?
Tilray-Aphria merger closes, expanded company to control biggest share of Canadian pot market. Canadian cannabis companies Tilray Inc. and Aphria Inc. say their merger deal has now closed after receiving approval from shareholders of both companies.May 3, 2021
Should you buy TLRY stock?
Shares of Tilray are not in a base or in buy range. So TLRY stock is not a buy right now. IBD advises investors to focus on stocks with stronger fundamentals that are moving into buy zones.
The cannabis company could deliver sizable gains to investors, according to one analyst
Joe honed his investing skills as an analyst for Stock Advisor, Supernova, and Fool One. He battle-tested his investment philosophy and strategies as portfolio manager of Tier 1, a market-crushing Motley Fool real-money portfolio that delivered 24.58% annualized returns during its existence.
What happened
Shares of Aphria ( NASDAQ:APHA) popped 12.3% on Monday, following bullish analyst comments.
So what
Cantor Fitzgerald analyst Pablo Zuanic named Aphria his top pick among Canadian cannabis stocks. He also boosted his price forecast from $7.86 to $8.23. Zuanic's new target price represents potential gains for investors of more than 40%, based on Aphria's closing stock price of $5.74.
Now what
Analysts are becoming more bullish on the cannabis industry's growth prospects, with some going so far as to predict that the U.S. could legalize marijuana at the federal level as early as 2021 should former Vice President Joe Biden win the presidential election in November and the Democrats gain control of Congress.
How much money did Constellation invest in Canopy Growth?
Constellation added to its initial $4 billion investment in Canopy Growth with another almost $200 million invested through warrants last year. Aurora Cannabis doesn't yet have any distribution framework set up for potential U.S. sales.
When will marijuana be legalized in Virginia?
Gov. Ralph Northam still needs to sign the bill, but he supports legalization, which will allow for sales to begin in 2024. Image source: Getty Images.
What is the ticker symbol for Tilray?
After the merger completion, the new entity trades under Tilray’s ticker symbol, “TLRY” on both the US and Canadian stock exchanges. In a press release, Tilray said that the combined entity had proforma revenue of $685 million in the last year.
Is Aphria a Tilray?
Aphria has stopped trading and all Aphria shares are now converted to Tilray shares. The merger had got delayed due to the delay in approval from Tilray shareholders.
Aphria is benefiting from Aurora Cannabis's most recent earnings report
A Fool since 2019, Prosper's writing focuses primarily on the healthcare sector. Passionate about teaching and learning, he enjoys helping others make better decisions about their finances -- and enjoys it just as much when they return the favor. In his free time, you'll find him curling up with a good book or doing math.
What happened?
Aphria ( NASDAQ:APHA) ended the week on a strong note. Shares of the Ontario-based cannabis company climbed by 11.3% on Friday, despite the company not reporting any news.
So what
There was little hope that Aurora Cannabis would be able to deliver strong financial results, especially after Tilray ( NASDAQ:TLRY) -- another big player in the marijuana industry -- disappointed with its own earnings report.
Now what
For its part, Aphria has consistently delivered strong financial results of late, especially when compared to its peers in the cannabis industry. For instance, in its most recent quarterly update, the company recorded a net revenue of 144.4 million Canadian dollars, a 19.8% sequential increase.
Where did Howard Howard grow up?
Howard grew up in Philadelphia watching the Philly sports teams struggle for championships. He has been investing since 1989 and been a Fool since 2001. Prior to joining The Fool as a contract writer in 2019, Howard worked in the steel business as an engineer for 28 years.
Who is the CEO of Aphria?
The combined company would be one of the largest global cannabis companies. Aphria CEO Irwin Simon will lead the combined company after the merger, which is expected to close by the end of the second quarter. The trend toward the legal use of cannabis is also impacting the smaller OrganiGram.
It's good news all around for the marijuana marketers
I like things that go "boom." Sonic or otherwise, that means I tend to gravitate towards defense and aerospace stocks. But to tell the truth, over the course of a dozen years writing for The Motley Fool, I have covered -- and continue to cover -- everything from retailers to consumer goods stocks, and from tech to banks to insurers as well.
What happened
Marijuana stocks Canopy Growth ( NASDAQ:CGC), Aphria ( NASDAQ:APHA), and Tilray ( NASDAQ:TLRY) all jumped in early Tuesday trading, but for different reasons.
So what
This morning, Canopy Growth announced it is launching a line of "scientifically backed CBD wellness solutions for canines developed by Martha Stewart with her own beloved dogs in mind."
Now what
As the headlining company name in the announcement from France, Tilray is naturally enjoying the bulk of the stock gains today -- naturally, but not necessarily correctly.